Checking in on Supernus Pharmaceuticals Inc (SUPN) after recent insiders movement

Supernus Pharmaceuticals Inc’s filing revealed that its Director Sensenig Bethany unloaded Company’s shares for reported $0.23 million on Aug 14 ’25. In the deal valued at $42.25 per share,5,369 shares were sold. As a result of this transaction, Sensenig Bethany now holds 0 shares worth roughly $0.0.

Then, Hudson Frederick M. sold 7,457 shares, generating $315,133 in total proceeds. Upon selling the shares at $42.26, the Director now owns 46,307 shares.

Before that, FREDERICK M HUDSON bought 7,457 shares. Supernus Pharmaceuticals Inc shares valued at $315,116 were divested by the Director at a price of $42.26 per share.

Cantor Fitzgerald upgraded its Supernus Pharmaceuticals Inc [SUPN] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who decreased its forecast for the stock in mid February from “an Overweight” to “a Neutral”. Cantor Fitzgerald began covering SUPN with “an Overweight” recommendation on January 06, 2025. Piper Sandler revised its rating on September 11, 2024. It rated SUPN as “a Neutral” which previously was an “an Overweight”.

Price Performance Review of SUPN

On Tuesday, Supernus Pharmaceuticals Inc [NASDAQ:SUPN] saw its stock fall -2.30% to $42.0. Over the last five days, the stock has gained 1.84%. Supernus Pharmaceuticals Inc shares have risen nearly 22.63% since the year began. Nevertheless, the stocks have risen 16.15% over the past one year. While a 52-week high of $43.73 was reached on 08/18/25, a 52-week low of $29.16 was recorded on 05/07/25.

Levels Of Support And Resistance For SUPN Stock

The 24-hour chart illustrates a support level at 41.62, which if violated will result in even more drops to 41.23. On the upside, there is a resistance level at 42.73. A further resistance level may holdings at 43.45.

How much short interest is there in Supernus Pharmaceuticals Inc?

A steep rise in short interest was recorded in Supernus Pharmaceuticals Inc stocks on 2025-07-31, growing by 0.18 million shares to a total of 5.08 million shares. Yahoo Finance data shows the prior-month short interest on 2025-06-30 was 4.9 million shares. There was a rise of 3.6%, which implies that there is a positive sentiment for the stock.

Most Popular

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.